Vault-13

VALEANT PHARMACEUTICALS INTL

COM · CUSIP 91911K102

1 institutional holders +0 vs Q2 2023
850,000850.0k shares reported held*
$7.0mreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $622.9k (-75.8k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.22.

Trends to Q3 2023

Institutional holders

Managers reporting a position, each quarter

001Q3 22: 1Q4 22: 1Q1 23: 1Q2 23: 1Q3 23: 11Q3 22Q4 22Q1 23Q2 23Q3 23
Numbers
QuarterHolders
Q3 20221
Q4 20221
Q1 20231
Q2 20231
Q3 20231

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q4 22: 0 bought or addedQ4 22: 0 cut or sold outQ4 22Q1 23: 0 bought or addedQ1 23: 1 cut or sold outQ1 23Q2 23: 0 bought or addedQ2 23: 0 cut or sold outQ2 23Q3 23: 0 bought or addedQ3 23: 1 cut or sold outQ3 23
Numbers
QuarterBought or addedCut or sold out
Q4 202200
Q1 202301
Q2 202300
Q3 202301

Biggest buyers

None

Biggest sellers

Bruce & Co., Inc. Reduced -75,780-75.8k

Holders, Q3 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Bruce & Co., Inc. 2.38% of their portfolio CHICAGO, IL 850,000850.0k $7.0m $7.0m 2.38% Reduced -75.8k -75,780